Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Satoshi Nakahara"'
Autor:
Satoshi Nakahara, Yumiko Ishii, Reika Egashira, Kazuya Tsubouchi, Mikihiro Kohno, Tomoyoshi Takenaka, Kentaro Tanaka, Isamu Okamoto
Publikováno v:
Respirology Case Reports, Vol 12, Iss 5, Pp n/a-n/a (2024)
Abstract We report the first case of drug‐induced interstitial lung disease attributed to lemborexant. A 66‐year‐old man reported to our hospital with the acute onset of cough and breathlessness with ground‐glass opacity on radiological exami
Externí odkaz:
https://doaj.org/article/9dcb7b72ab2a420b8d26c0d1a0234d11
Autor:
Azusa Miyashita, Satoshi Fukushima, Satoshi Nakahara, Junji Yamashita, Aki Tokuzumi, Jun Aoi, Asako Ichihara, Hisashi Kanemaru, Masatoshi Jinnin, Hironobu Ihn
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0144241 (2015)
Recent studies have shown that immunotherapies and molecular targeted therapies are effective for advanced melanoma. Non-antigen-specific immunotherapies such as immunocheckpoint blockades have been shown to be effective in the treatment of advanced
Externí odkaz:
https://doaj.org/article/68f18cff6df44cbfb3777e62ee8ea776
Autor:
Satoshi Fukushima, Azusa Miyashita, Haruka Kuriyama, Toshihiro Kimura, Satoru Mizuhashi, Yosuke Kubo, Satoshi Nakahara, Hisashi Kanemaru, Nobuhiro Tsuchiya, Hiroaki Mashima, Rong Zhang, Yasushi Uemura
Publikováno v:
Experimental Dermatology. 32:290-296
Cancer immunotherapy is now the first-line treatment for many unresectable cancers. However, it remains far from a complete cure for all patients. Therefore, it is necessary to develop innovative methods for cancer immunotherapy, and immune cell ther
Autor:
Yoshihiro Komohara, Motohiro Takeya, Hironobu Ihn, Masatoshi Jinnin, Satoshi Fukushima, Takanobu Motoshima, Hasita Horlad, Yukio Fujiwara, Satoshi Nakahara, Azusa Miyashita, Koji Ohnishi, Yoichi Saito
Table S1. Additional univariate (A) and multivariate (B) Cox regression analyses of potential prognostic factors for overall survival. Figure S1. Decolorized sections. Immunostaining of the negative control melanomas and RLNs treated with or without
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1db39a7a8379b94e256b770290f55485
https://doi.org/10.1158/2326-6066.22538629
https://doi.org/10.1158/2326-6066.22538629
Autor:
Yoshihiro Komohara, Motohiro Takeya, Hironobu Ihn, Masatoshi Jinnin, Satoshi Fukushima, Takanobu Motoshima, Hasita Horlad, Yukio Fujiwara, Satoshi Nakahara, Azusa Miyashita, Koji Ohnishi, Yoichi Saito
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::085541b4df298709dacb9f3dbc40ce3e
https://doi.org/10.1158/2326-6066.22538638.v1
https://doi.org/10.1158/2326-6066.22538638.v1
Autor:
Yoshihiro Komohara, Motohiro Takeya, Hironobu Ihn, Masatoshi Jinnin, Satoshi Fukushima, Takanobu Motoshima, Hasita Horlad, Yukio Fujiwara, Satoshi Nakahara, Azusa Miyashita, Koji Ohnishi, Yoichi Saito
CD169 (sialoadhesin) is a sialic acid receptor that is specifically expressed on macrophages, including lymph node sinus macrophages. Animal studies suggest that CD169+ macrophages in lymph nodes have properties in preventing cancers. In order to det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62043093fc09f05eaa9b05ff6f83f2fd
https://doi.org/10.1158/2326-6066.c.6548836.v1
https://doi.org/10.1158/2326-6066.c.6548836.v1
Autor:
Hironobu Ihn, Masatoshi Jinnin, Yasuharu Nishimura, Satoru Senju, Miwa Haruta, Jun Aoi, Junji Yamashita, Aki Tokuzumi, Yosuke Kubo, Satoshi Nakahara, Satoshi Fukushima, Azusa Miyashita
We observed malignant tumor development from human iPS-ML-IFN cells in SCID mice for up to 12 weeks. During the observation period, the mice were healthy, and no significant difference was observed in the body weight of human iPS-ML-IFN-injected mice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be0bb70fefd82b2d50fdb4476533e60d
https://doi.org/10.1158/2326-6066.22537568
https://doi.org/10.1158/2326-6066.22537568
Autor:
Hironobu Ihn, Masatoshi Jinnin, Yasuharu Nishimura, Satoru Senju, Miwa Haruta, Jun Aoi, Junji Yamashita, Aki Tokuzumi, Yosuke Kubo, Satoshi Nakahara, Satoshi Fukushima, Azusa Miyashita
In recent years, immunotherapy for advanced melanoma has been gaining increased attention. The efficacy of anti-cytotoxic T-lymphocyte antigen 4 antibodies, anti-programmed cell death 1 antibodies, and the BRAFV600E kinase inhibitor has been proven i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5490447426deb5ae6ecfa44cdceac240
https://doi.org/10.1158/2326-6066.c.6548480.v1
https://doi.org/10.1158/2326-6066.c.6548480.v1
Autor:
Hirotake Tsukamoto, Jun Aoi, Aki Tokuzumi, Yosuke Kubo, Katsunari Makino, Takashi Inozume, Satoshi Fukushima, Satoru Senju, Hironobu Ihn, Toshihiro Kimura, Takamitsu Makino, Rong Zhang, Mina Kadohisa-Tsuruta, Yasushi Uemura, Ikko Kajihara, Hisashi Kanemaru, Satoshi Nakahara, Etsuko Okada, Haruka Kuriyama, Azusa Miyashita, Yasuharu Nishimura
Publikováno v:
Pigment Cell & Melanoma Research. 33:744-755
Immune checkpoint inhibitors improved the survival rate of patients with unresectable melanoma. However, some patients do not respond, and variable immune-related adverse events have been reported. Therefore, more effective and antigen-specific immun
Autor:
Ru-Shi Liu, Zhen Bao, Kashyap Dave, Yoshihiko Kanemitsu, Satoshi Nakahara, Keiichi Ohara, Hirokazu Tahara, Sojiro Masada
Publikováno v:
Nanoscale. 12:3820-3826
Surface defects and synthesis methods play important roles in the photoluminescence quantum yield (PLQY), stability, and the device performance of lead halide perovskite quantum dots (PQDs). In this study, we report a quadruple-ligand (tri-n-octylpho